Source comparison
BPC-157 Studied Stress Fracture: Comparison Across Bone Healing Interventions
BPC-157 (animal models) VEGF upregulation, eNOS activation, MSC recruitment to fracture site 40–60% faster radiographic union in rodent studies Controlled animal trials; no Phase III human data Not FDA-approved; requires subcutaneous injection; dosing extrapol
This comparison does not assign a generated winner or score.
- BPC-157 (animal models)
- VEGF upregulation, eNOS activation, MSC recruitment to fracture site
- 40–60% faster radiographic union in rodent studies
- Controlled animal trials; no Phase III human data
- Not FDA-approved; requires subcutaneous injection; dosing extrapolation uncertain
- Strongest preclinical evidence for stress fracture acceleration, but human application remains investigational
- Pulsed Electromagnetic Field (PEMF)
- Enhances calcium ion flux across cell membranes, promotes osteoblast activity
- 20–30% faster healing in clinical trials
- Multiple randomised controlled human trials
- Requires daily device use (30–60 min); effectiveness varies by fracture location
- FDA-cleared for delayed union/nonunion; good safety profile but moderate efficacy
- Low-Intensity Pulsed Ultrasound (LIPUS)
- Mechanical stimulation increases prostaglandin synthesis, upregulates TGF-beta
- 25–40% faster healing in fresh fractures
- Mixed human trial results; meta-analyses show modest benefit
- Daily 20-min sessions required; device cost $3,000–$5,000
- FDA-cleared but 2020 Cochrane review found limited evidence for stress fractures specifically
- Calcium + Vitamin D supplementation
- Provides mineral substrate for bone mineralisation; supports parathyroid hormone regulation
- 10–15% improvement in deficient patients only
- Observational studies; no RCTs showing fracture acceleration in healthy adults
- No effect if baseline levels adequate; high-dose vitamin D (>4,000 IU/day) requires monitoring
- Essential for deficiency correction but not a standalone accelerant
- Bone morphogenetic protein (BMP-2)
- Direct osteoinductive signal; recruits osteoprogenitor cells to fracture site
- 30–50% faster union in surgical nonunion cases
- FDA-approved for spinal fusion; limited stress fracture data
- Off-label for stress fractures; risk of heterotopic ossification; cost $5,000+ per dose
- Proven for surgical applications but excessive for typical stress fractures